STERIS PLC (STE) Stock Price, Quote, News and Overview
NYSE:STE - New York Stock Exchange, Inc. - IE00BFY8C754 - Common Stock - Currency: USD
STE Quote, Performance and Key Statistics
225
-1.35 (-0.6%)
The current stock price of STE is 225 USD. In the past month the price increased by 0.34%. In the past year, price increased by 10.35%.
STE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 26.96 | 223.47B | ||
| ISRG | INTUITIVE SURGICAL INC | 67.35 | 184.36B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.74 | 150.72B | ||
| SYK | STRYKER CORP | 29.95 | 139.34B | ||
| MDT | MEDTRONIC PLC | 15.76 | 107.94B | ||
| BDX | BECTON DICKINSON AND CO | 14.74 | 58.89B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.25 | 44.70B | ||
| IDXX | IDEXX LABORATORIES INC | 38.88 | 35.45B | ||
| RMD | RESMED INC | 25.98 | 34.64B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.24 | 31.33B | ||
| DXCM | DEXCOM INC | 43.43 | 28.10B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 15.84 | 23.53B |
Related stock screener links
About STE
Company Profile
STERIS Plc engages in the provision of healthcare and life science products and service solutions. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
Company Info
STERIS PLC
70 Sir John Rogerson's Quay
DUBLIN D02 R296 IE
CEO: Walter M Rosebrough
Employees: 18000
Company Website: https://www.steris.com/
Investor Relations: https://sterisplc.gcs-web.com
Phone: 35312322000
STERIS PLC / STE FAQ
What is the stock price of STERIS PLC today?
The current stock price of STE is 225 USD. The price decreased by -0.6% in the last trading session.
What is the ticker symbol for STERIS PLC stock?
The exchange symbol of STERIS PLC is STE and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is STE stock listed?
STE stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for STERIS PLC stock?
11 analysts have analysed STE and the average price target is 258.38 USD. This implies a price increase of 14.84% is expected in the next year compared to the current price of 225. Check the STERIS PLC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is STERIS PLC worth?
STERIS PLC (STE) has a market capitalization of 22.11B USD. This makes STE a Large Cap stock.
How many employees does STERIS PLC have?
STERIS PLC (STE) currently has 18000 employees.
What are the support and resistance levels for STERIS PLC (STE) stock?
STERIS PLC (STE) has a support level at 223.9 and a resistance level at 226.02. Check the full technical report for a detailed analysis of STE support and resistance levels.
Is STERIS PLC (STE) expected to grow?
The Revenue of STERIS PLC (STE) is expected to grow by 0.05% in the next year. Check the estimates tab for more information on the STE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy STERIS PLC (STE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of STE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of STE, evaluating the profitability, health, valuation and growth aspects
- STERIS PLC (STE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- STERIS PLC (STE) Sales and EPS estimates to see what analysts future expectations are.
- STERIS PLC (STE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- STERIS PLC (STE) Insider and Institutional Ownership to learn about the owners and their transactions.
- STERIS PLC (STE) Stock Chart to make your own analysis
- STERIS PLC (STE) Latest news and press-releases to stay up to date.
Does STERIS PLC (STE) stock pay dividends?
STERIS PLC (STE) has a dividend yield of 1.03%. The yearly dividend amount is currently 2.03. Check the full fundamental report for a detailed analysis of STE dividend history, reliability and sustainability.
When does STERIS PLC (STE) report earnings?
STERIS PLC (STE) will report earnings on 2025-05-06, after the market close.
What is the Price/Earnings (PE) ratio of STERIS PLC (STE)?
The PE ratio for STERIS PLC (STE) is 24.51. This is based on the reported non-GAAP earnings per share of 9.18 and the current share price of 225 USD. Check the full fundamental report for a full analysis of the valuation metrics for STE.
What is the Short Interest ratio of STERIS PLC (STE) stock?
The outstanding short interest for STERIS PLC (STE) is 1.18% of its float. Check the ownership tab for more information on the STE short interest.
STE Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to STE. When comparing the yearly performance of all stocks, STE is one of the better performing stocks in the market, outperforming 81.71% of all stocks.
STE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to STE. While STE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
STE Financial Highlights
Over the last trailing twelve months STE reported a non-GAAP Earnings per Share(EPS) of 9.18. The EPS increased by 7.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.18% | ||
| ROA | 4.67% | ||
| ROE | 7.27% | ||
| Debt/Equity | 0.32 |
STE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 76% to STE. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 3.55% and a revenue growth 0.05% for STE